Targeting metabotropic glutamate receptors for the treatment of neuroinflammation

Francesco Fazio, Martina Ulivieri, Claudia Volpi, Marco Gargaro, Francesca Fallarino

Research output: Contribution to journalReview article

7 Citations (Scopus)

Abstract

A large body of evidence suggests that neuroinflammation lies at the core of nearly all CNS disorders, including psychiatric disorders. Invading and local immune cells orchestrate the series of events that lead to either tissue repair or damage in response to neuroinflammation. Both lymphocytes and microglia express metabotropic glutamate (mGlu) receptors, which respond to glutamate or other endogenous activators (e.g. some kynurenine metabolites of tryptophan metabolism) influencing immune phenotype and the balance between pro-inflammatory and anti-inflammatory cytokines. Here, we offer an up-to-date on the role of individual mGlu receptor subtypes in the regulation of innate and adaptive immune response, highlighting the relevance of this information in the development of subtype-selective mGlu receptor ligands for treatment of CNS disorders.

Original languageEnglish
Pages (from-to)16-23
Number of pages8
JournalCurrent Opinion in Pharmacology
Volume38
DOIs
Publication statusPublished - Feb 1 2018

Fingerprint

Metabotropic Glutamate Receptors
Kynurenine
Microglia
Adaptive Immunity
Innate Immunity
Tryptophan
Psychiatry
Glutamic Acid
Anti-Inflammatory Agents
Lymphocytes
Cytokines
Ligands
Phenotype

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Cite this

Targeting metabotropic glutamate receptors for the treatment of neuroinflammation. / Fazio, Francesco; Ulivieri, Martina; Volpi, Claudia; Gargaro, Marco; Fallarino, Francesca.

In: Current Opinion in Pharmacology, Vol. 38, 01.02.2018, p. 16-23.

Research output: Contribution to journalReview article

Fazio, Francesco ; Ulivieri, Martina ; Volpi, Claudia ; Gargaro, Marco ; Fallarino, Francesca. / Targeting metabotropic glutamate receptors for the treatment of neuroinflammation. In: Current Opinion in Pharmacology. 2018 ; Vol. 38. pp. 16-23.
@article{ba802c6728534ddc990fe137d431cbfe,
title = "Targeting metabotropic glutamate receptors for the treatment of neuroinflammation",
abstract = "A large body of evidence suggests that neuroinflammation lies at the core of nearly all CNS disorders, including psychiatric disorders. Invading and local immune cells orchestrate the series of events that lead to either tissue repair or damage in response to neuroinflammation. Both lymphocytes and microglia express metabotropic glutamate (mGlu) receptors, which respond to glutamate or other endogenous activators (e.g. some kynurenine metabolites of tryptophan metabolism) influencing immune phenotype and the balance between pro-inflammatory and anti-inflammatory cytokines. Here, we offer an up-to-date on the role of individual mGlu receptor subtypes in the regulation of innate and adaptive immune response, highlighting the relevance of this information in the development of subtype-selective mGlu receptor ligands for treatment of CNS disorders.",
author = "Francesco Fazio and Martina Ulivieri and Claudia Volpi and Marco Gargaro and Francesca Fallarino",
year = "2018",
month = "2",
day = "1",
doi = "10.1016/j.coph.2018.01.010",
language = "English",
volume = "38",
pages = "16--23",
journal = "Current Opinion in Pharmacology",
issn = "1471-4892",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Targeting metabotropic glutamate receptors for the treatment of neuroinflammation

AU - Fazio, Francesco

AU - Ulivieri, Martina

AU - Volpi, Claudia

AU - Gargaro, Marco

AU - Fallarino, Francesca

PY - 2018/2/1

Y1 - 2018/2/1

N2 - A large body of evidence suggests that neuroinflammation lies at the core of nearly all CNS disorders, including psychiatric disorders. Invading and local immune cells orchestrate the series of events that lead to either tissue repair or damage in response to neuroinflammation. Both lymphocytes and microglia express metabotropic glutamate (mGlu) receptors, which respond to glutamate or other endogenous activators (e.g. some kynurenine metabolites of tryptophan metabolism) influencing immune phenotype and the balance between pro-inflammatory and anti-inflammatory cytokines. Here, we offer an up-to-date on the role of individual mGlu receptor subtypes in the regulation of innate and adaptive immune response, highlighting the relevance of this information in the development of subtype-selective mGlu receptor ligands for treatment of CNS disorders.

AB - A large body of evidence suggests that neuroinflammation lies at the core of nearly all CNS disorders, including psychiatric disorders. Invading and local immune cells orchestrate the series of events that lead to either tissue repair or damage in response to neuroinflammation. Both lymphocytes and microglia express metabotropic glutamate (mGlu) receptors, which respond to glutamate or other endogenous activators (e.g. some kynurenine metabolites of tryptophan metabolism) influencing immune phenotype and the balance between pro-inflammatory and anti-inflammatory cytokines. Here, we offer an up-to-date on the role of individual mGlu receptor subtypes in the regulation of innate and adaptive immune response, highlighting the relevance of this information in the development of subtype-selective mGlu receptor ligands for treatment of CNS disorders.

UR - http://www.scopus.com/inward/record.url?scp=85042196514&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042196514&partnerID=8YFLogxK

U2 - 10.1016/j.coph.2018.01.010

DO - 10.1016/j.coph.2018.01.010

M3 - Review article

AN - SCOPUS:85042196514

VL - 38

SP - 16

EP - 23

JO - Current Opinion in Pharmacology

JF - Current Opinion in Pharmacology

SN - 1471-4892

ER -